2171
HKSE:2171
CARsgen Therapeutics Holdings Limited
- Stock
locale
Chinamarket
STOCKSindustry
Biotechnologywebsite
www.carsgen.comipo date
Jun 18, 2021
CARsgen Therapeutics Holdings Limited, a biopharmaceutical company, engages in discovering, developing, and commercializing chimeric antigen receptor T (CAR-T) cell therapies for the treatment of hematological malignancies and solid tumors in China and the United States. The company is involved in developing CT053, an autologous CAR-T product candidate that is in pivotal Phase ...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus